148 related articles for article (PubMed ID: 18193232)
21. Etanercept and urticaria in patients with juvenile idiopathic arthritis.
Skyttä E; Pohjankoski H; Savolainen A
Clin Exp Rheumatol; 2000; 18(4):533-4. PubMed ID: 10949736
[TBL] [Abstract][Full Text] [Related]
22. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Kurosawa R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
Mod Rheumatol; 2011 Dec; 21(6):572-8. PubMed ID: 21479889
[TBL] [Abstract][Full Text] [Related]
23. Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?
Flemming GM; Tóth G; Gebauer C; Schuster V
Klin Padiatr; 2013 Nov; 225(6):350-1. PubMed ID: 24166091
[No Abstract] [Full Text] [Related]
24. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
[TBL] [Abstract][Full Text] [Related]
25. Response to etanercept in juvenile idiopathic arthritis.
Pang H; Wu XH; Xu JZ
JAMA; 2012 Mar; 307(11):1140; author reply 1140-1. PubMed ID: 22436950
[No Abstract] [Full Text] [Related]
26. Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis.
Simonini G; Giani T; Stagi S; de Martino M; Falcini F
Rheumatology (Oxford); 2005 Jun; 44(6):777-80. PubMed ID: 15741191
[TBL] [Abstract][Full Text] [Related]
27. The 'head-to-head' comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis.
Lamot L; Bukovac LT; Vidovic M; Frleta M; Harjacek M
Clin Exp Rheumatol; 2011; 29(1):131-9. PubMed ID: 21345300
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of plasma to reveal the impact of short-term etanercept therapy in pediatric patients with enthesitis-related arthritis: a case report.
Chen YC; Wang PW; Pan TL; Bazylak G; Shen JJ
Comb Chem High Throughput Screen; 2010 Jul; 13(6):469-81. PubMed ID: 20402637
[TBL] [Abstract][Full Text] [Related]
29. [Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee].
Horneff G; Forster J; Seyberth HW; Michels H;
Z Rheumatol; 2000 Dec; 59(6):365-9. PubMed ID: 11201000
[No Abstract] [Full Text] [Related]
30. Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis.
Geikowski T; Becker I; Horneff G;
Rheumatology (Oxford); 2014 Jul; 53(7):1245-9. PubMed ID: 24599916
[TBL] [Abstract][Full Text] [Related]
31. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis.
Liu SW; Velez NF; Lam C; Femia A; Granter SR; Townsend HB; Vleugels RA
JAMA Dermatol; 2013 Oct; 149(10):1204-8. PubMed ID: 23986394
[TBL] [Abstract][Full Text] [Related]
32. Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity.
Tuttle KS; Vargas SO; Callahan MJ; Bae DS; Nigrovic PA
Pediatr Rheumatol Online J; 2015; 13():7. PubMed ID: 25774101
[TBL] [Abstract][Full Text] [Related]
33. Etanercept in methotrexate-resistant JIA-related uveitis.
Saeed MU; Raza SH; Goyal S; Cleary G; Newman WD; Chandna A
Semin Ophthalmol; 2014 Jan; 29(1):1-3. PubMed ID: 24175644
[TBL] [Abstract][Full Text] [Related]
34. A follow-up study of patients with juvenile idiopathic arthritis who discontinued etanercept due to disease remission.
Pratsidou-Gertsi P; Trachana M; Pardalos G; Kanakoudi-Tsakalidou F
Clin Exp Rheumatol; 2010; 28(6):919-22. PubMed ID: 21205467
[TBL] [Abstract][Full Text] [Related]
35. Good results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritis.
Haapasaari J; Kautiainen H; Hannula S; Pohjankoski H; Hakala M
Clin Exp Rheumatol; 2002; 20(6):867-70. PubMed ID: 12508784
[TBL] [Abstract][Full Text] [Related]
36. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
Lovell DJ; Giannini EH; Reiff A; Cawkwell GD; Silverman ED; Nocton JJ; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Whitmore J; Finck BK
N Engl J Med; 2000 Mar; 342(11):763-9. PubMed ID: 10717011
[TBL] [Abstract][Full Text] [Related]
37. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.
Southwood TR; Foster HE; Davidson JE; Hyrich KL; Cotter CB; Wedderburn LR; Hull RG; Venning HE; Rahman JK; Cummins CL;
Rheumatology (Oxford); 2011 Jan; 50(1):189-95. PubMed ID: 21047801
[TBL] [Abstract][Full Text] [Related]
38. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
Prince FH; Geerdink LM; Borsboom GJ; Twilt M; van Rossum MA; Hoppenreijs EP; Cate RT; Koopman-Keemink Y; van Santen-Hoeufft M; Raat H; van Suijlekom-Smit LW
Ann Rheum Dis; 2010 Jan; 69(1):138-42. PubMed ID: 19581280
[TBL] [Abstract][Full Text] [Related]
39. Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis.
Nielsen S; Ruperto N; Gerloni V; Simonini G; Cortis E; Lepore L; Alpigiani MG; Zulian F; Corona F; Alessio M; Barcellona R; Gallizzi R; Rossi F; Magni-Manzoni S; Lombardini G; Filocamo G; Raschetti R; Martini A; Ravelli A;
Clin Exp Rheumatol; 2008; 26(4):688-92. PubMed ID: 18799107
[TBL] [Abstract][Full Text] [Related]
40. Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.
Katsicas MM; Russo RA
Clin Exp Rheumatol; 2005; 23(4):545-8. PubMed ID: 16095128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
